Quick Answer
Centessa Pharmaceuticals plc reported Total Assets of $687.50 million for fiscal year 2025.
Centessa Pharmaceuticals plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $687.50M | +19.2% |
| 2024 | $576.80M | +60.1% |
| 2023 | $360.25M | -18.9% |
| 2022 | $444.31M | -29.4% |
| 2021 | $629.63M | +5273.7% |
| 2020 | $11.72M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $448.30M | -26.5% | -8.9% |
| June 30, 2025 | $492.13M | +23.4% | -6.8% |
| March 31, 2025 | $527.85M | +60.8% | -8.5% |
| December 31, 2024 | $576.80M | +60.1% | -5.4% |
| September 30, 2024 | $609.72M | +61.6% | +52.9% |
| June 30, 2024 | $398.85M | +1.5% | +21.5% |
| March 31, 2024 | $328.17M | -18.7% | -8.9% |
| December 31, 2023 | $360.25M | -18.9% | -4.5% |
- Centessa Pharmaceuticals plc showed an increase of +19.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Centessa Pharmaceuticals plc’s total assets has grown by 5767.5% (from $11.72 million to $687.50 million).
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: